Fig. 2From: Clinical profiles of treated and untreated adults with hypophosphatasia in the Global HPP RegistrySummary of mean SF-36v2 scores at baseline among treated and untreated adults with pediatric-onset HPP. aBefore the start of ERT. bBased on normative data reported in Ware et al.3 for the 1998 US general population. ERT, enzyme replacement therapy; HPP, hypophosphatasia; HRQoL, health-related quality of life; SD, standard deviation; SF-36v2, 36-item Short Form Health Survey version 2; US, United StatesBack to article page